2KBY

The Tetramerization Domain of Human p73

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	2.5mM [U-13C; U-15N] p73 TD-1, 20mM sodium phosphate-2, 100mM sodium chloride-3	100% D2O			1 atm	303
2	3D NOESY-[15N,1H]-TROSY	2.5mM [U-15N] p73 TD-7, 20mM sodium phosphate-8, 100mM sodium chloride-9	95% H2O/5% D2O		7.0	1 atm	303
3	3D NOESY-[13C,1H]-HSQC	2.5mM [U-13C; U-15N] p73 TD-1, 20mM sodium phosphate-2, 100mM sodium chloride-3	100% D2O			1 atm	303
4	3D NOESY-[13C,1H]-HSQC	2.5mM [U-13C; U-15N] p73 TD-4, 20mM sodium phosphate-5, 100mM sodium chloride-6	95% H2O/5% D2O		7.0	1 atm	303
5	4D-CT-J-Resolved 13C-separated NOESY	2.5mM [U-15N] p73 TD-14, 2.5mM [U-13C] p73 TD-15, 20mM sodium phosphate-16, 100mM sodium chloride-17	100% D2O			1 atm	303
6	3D 15N-edited/13C-separated NOESY	2.5mM [U-15N] p73 TD-10, 2.5mM [U-13C] p73 TD-11, 20mM sodium phosphate-12, 100mM sodium chloride-13	95% H2O/5% D2O		7.0	1 atm	303
7	3D 15N/13C-separated NOESY	2.5mM [U-15N] p73 TD-10, 2.5mM [U-13C] p73 TD-11, 20mM sodium phosphate-12, 100mM sodium chloride-13	95% H2O/5% D2O		7.0	1 atm	303
8	3D HNCACB	2.5mM [U-13C; U-15N] p73 TD-4, 20mM sodium phosphate-5, 100mM sodium chloride-6	95% H2O/5% D2O		7.0	1 atm	303
9	3D HN(CO)CA	2.5mM [U-13C; U-15N] p73 TD-4, 20mM sodium phosphate-5, 100mM sodium chloride-6	95% H2O/5% D2O		7.0	1 atm	303
10	3D HNCO	2.5mM [U-13C; U-15N] p73 TD-4, 20mM sodium phosphate-5, 100mM sodium chloride-6	95% H2O/5% D2O		7.0	1 atm	303
11	3D H(CCO)NH	2.5mM [U-13C; U-15N] p73 TD-4, 20mM sodium phosphate-5, 100mM sodium chloride-6	95% H2O/5% D2O		7.0	1 atm	303
12	3D C(CO)NH	2.5mM [U-13C; U-15N] p73 TD-4, 20mM sodium phosphate-5, 100mM sodium chloride-6	95% H2O/5% D2O		7.0	1 atm	303
13	TOCSY-[15N,1H]-TROSY	2.5mM [U-15N] p73 TD-7, 20mM sodium phosphate-8, 100mM sodium chloride-9	95% H2O/5% D2O		7.0	1 atm	303
14	CT-[13C,1H]-HSQC	2.5mM [U-10% 13C] p73 TD-18, 20mM sodium phosphate-19, 100mM sodium chloride-20	95% H2O/5% D2O		7.0	1 atm	303
15	C-coupled HA(CACO)NH	2.5mM [U-13C; U-15N] p73 TD-21, 16.4 Hz Pf1 phage-22, 50mM arginine-23, 50mM glutamate-24	95% H2O/5% D2O		6.8	1 atm	303
16	F2-IPAP-CT-[13C,1H]-HSQC	2.5mM [U-13C; U-15N] p73 TD-21, 16.4 Hz Pf1 phage-22, 50mM arginine-23, 50mM glutamate-24	95% H2O/5% D2O		6.8	1 atm	303
17	[15N,1H]-TROSY/anti-TROSY	2.5mM [U-13C; U-15N] p73 TD-21, 16.4 Hz Pf1 phage-22, 50mM arginine-23, 50mM glutamate-24	95% H2O/5% D2O		6.8	1 atm	303
18	HN-TROSY IPAP	2.5mM [U-13C; U-15N] p73 TD-21, 16.4 Hz Pf1 phage-22, 50mM arginine-23, 50mM glutamate-24	95% H2O/5% D2O		6.8	1 atm	303
19	C-coupled HNCO	2.5mM [U-13C; U-15N] p73 TD-21, 16.4 Hz Pf1 phage-22, 50mM arginine-23, 50mM glutamate-24	95% H2O/5% D2O		6.8	1 atm	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
torsion angle dynamics		ARIA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	The structure was determined using a combination of NOE and residual dipolar coupling data.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	automatic assignment	ARIA	2.2	Linge, O'Donoghue, Nilges
2	structure solution	ARIA	2.2	Linge, O'Donoghue, Nilges
3	refinement	ARIA	2.2	Linge, O'Donoghue, Nilges